148 related articles for article (PubMed ID: 36711875)
1. Oleoylethanolamide facilitates PPARa and TFEB signaling and attenuates Ab pathology in a mouse model of Alzheimer's disease.
Comerota M; Gedam M; Xiong W; Jin F; Deng L; Wang M; Wang J; Zheng H
Res Sq; 2023 Jan; ():. PubMed ID: 36711875
[TBL] [Abstract][Full Text] [Related]
2. Oleoylethanolamide facilitates PPARα and TFEB signaling and attenuates Aβ pathology in a mouse model of Alzheimer's disease.
Comerota MM; Gedam M; Xiong W; Jin F; Deng L; Wang MC; Wang J; Zheng H
Mol Neurodegener; 2023 Aug; 18(1):56. PubMed ID: 37580742
[TBL] [Abstract][Full Text] [Related]
3. Microglial amyloid beta clearance is driven by PIEZO1 channels.
Jäntti H; Sitnikova V; Ishchenko Y; Shakirzyanova A; Giudice L; Ugidos IF; Gómez-Budia M; Korvenlaita N; Ohtonen S; Belaya I; Fazaludeen F; Mikhailov N; Gotkiewicz M; Ketola K; Lehtonen Š; Koistinaho J; Kanninen KM; Hernández D; Pébay A; Giugno R; Korhonen P; Giniatullin R; Malm T
J Neuroinflammation; 2022 Jun; 19(1):147. PubMed ID: 35706029
[TBL] [Abstract][Full Text] [Related]
4. Aspirin Induces Lysosomal Biogenesis and Attenuates Amyloid Plaque Pathology in a Mouse Model of Alzheimer's Disease via PPARα.
Chandra S; Jana M; Pahan K
J Neurosci; 2018 Jul; 38(30):6682-6699. PubMed ID: 29967008
[TBL] [Abstract][Full Text] [Related]
5. LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.
Yang Y; García-Cruzado M; Zeng H; Camprubí-Ferrer L; Bahatyrevich-Kharitonik B; Bachiller S; Deierborg T
Brain Behav Immun; 2023 Oct; 113():228-247. PubMed ID: 37437821
[TBL] [Abstract][Full Text] [Related]
6. Gossypetin ameliorates 5xFAD spatial learning and memory through enhanced phagocytosis against Aβ.
Jo KW; Lee D; Cha DG; Oh E; Choi YH; Kim S; Park ES; Kim JK; Kim KT
Alzheimers Res Ther; 2022 Oct; 14(1):158. PubMed ID: 36271414
[TBL] [Abstract][Full Text] [Related]
7. Oleoylethanolamide Protects against Acute Ischemic Stroke by Promoting PPARα-Mediated Microglia/Macrophage M2 Polarization.
Li Y; Zhang Y; Wang Q; Wu C; Du G; Yang L
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111378
[TBL] [Abstract][Full Text] [Related]
8. TNEA therapy promotes the autophagic degradation of NLRP3 inflammasome in a transgenic mouse model of Alzheimer's disease via TFEB/TFE3 activation.
Lin W; Li Z; Liang G; Zhou R; Zheng X; Tao R; Huo Q; Su C; Li M; Xu N; Tang C; Song JX
J Neuroinflammation; 2023 Feb; 20(1):21. PubMed ID: 36732771
[TBL] [Abstract][Full Text] [Related]
9. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models.
Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M
Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997
[TBL] [Abstract][Full Text] [Related]
10. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
Lantz MJ; Roberts AM; Delgado DD; Nichols RA
J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
[TBL] [Abstract][Full Text] [Related]
11. Hederagenin improves Alzheimer's disease through PPARα/TFEB-mediated autophagy.
Xie ZS; Zhao JP; Wu LM; Chu S; Cui ZH; Sun YR; Wang H; Ma HF; Ma DR; Wang P; Zhang XW; Zhang ZQ
Phytomedicine; 2023 Apr; 112():154711. PubMed ID: 36809694
[TBL] [Abstract][Full Text] [Related]
12. Chronic oleoylethanolamide treatment attenuates diabetes-induced mice encephalopathy by triggering peroxisome proliferator-activated receptor alpha in the hippocampus.
Ren T; Liu J; Ge Y; Zhuo R; Peng L; Liu F; Jin X; Yang L
Neurochem Int; 2019 Oct; 129():104501. PubMed ID: 31299417
[TBL] [Abstract][Full Text] [Related]
13. Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer's disease by restoring microglial function via a PPAR-γ-dependent mechanism.
Medrano-Jiménez E; Jiménez-Ferrer Carrillo I; Pedraza-Escalona M; Ramírez-Serrano CE; Álvarez-Arellano L; Cortés-Mendoza J; Herrera-Ruiz M; Jiménez-Ferrer E; Zamilpa A; Tortoriello J; Pedraza-Alva G; Pérez-Martínez L
J Neuroinflammation; 2019 Jul; 16(1):143. PubMed ID: 31291963
[TBL] [Abstract][Full Text] [Related]
14. Deacetylation of TFEB promotes fibrillar Aβ degradation by upregulating lysosomal biogenesis in microglia.
Bao J; Zheng L; Zhang Q; Li X; Zhang X; Li Z; Bai X; Zhang Z; Huo W; Zhao X; Shang S; Wang Q; Zhang C; Ji J
Protein Cell; 2016 Jun; 7(6):417-33. PubMed ID: 27209302
[TBL] [Abstract][Full Text] [Related]
15. Cu(II) disrupts autophagy-mediated lysosomal degradation of oligomeric Aβ in microglia via mTOR-TFEB pathway.
Tan X; Guan H; Yang Y; Luo S; Hou L; Chen H; Li J
Toxicol Appl Pharmacol; 2020 Aug; 401():115090. PubMed ID: 32512069
[TBL] [Abstract][Full Text] [Related]
16. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
[TBL] [Abstract][Full Text] [Related]
17. Enhancing astrocytic lysosome biogenesis facilitates Aβ clearance and attenuates amyloid plaque pathogenesis.
Xiao Q; Yan P; Ma X; Liu H; Perez R; Zhu A; Gonzales E; Burchett JM; Schuler DR; Cirrito JR; Diwan A; Lee JM
J Neurosci; 2014 Jul; 34(29):9607-20. PubMed ID: 25031402
[TBL] [Abstract][Full Text] [Related]
18. Nogo receptor impairs the clearance of fibril amyloid-β by microglia and accelerates Alzheimer's-like disease progression.
Wang J; Qin X; Sun H; He M; Lv Q; Gao C; He X; Liao H
Aging Cell; 2021 Dec; 20(12):e13515. PubMed ID: 34821024
[TBL] [Abstract][Full Text] [Related]
19. The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function.
Marsh SE; Abud EM; Lakatos A; Karimzadeh A; Yeung ST; Davtyan H; Fote GM; Lau L; Weinger JG; Lane TE; Inlay MA; Poon WW; Blurton-Jones M
Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1316-25. PubMed ID: 26884167
[TBL] [Abstract][Full Text] [Related]
20. Microglial VPS35 deficiency impairs Aβ phagocytosis and Aβ-induced disease-associated microglia, and enhances Aβ associated pathology.
Ren X; Yao L; Wang Y; Mei L; Xiong WC
J Neuroinflammation; 2022 Mar; 19(1):61. PubMed ID: 35236374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
